On an adjusted basis, Lilly earned $3.34 per share for the quarter, compared with analysts’ estimates of $3.02 per share ...

Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard Jorgensen is stepping down, as its obesity injection Wegovy loses ground to Eli ... to lower drug prices and ...

This proves that Eli Lilly's obesity drug Zepbound, as a GLP-1/GIP agonist ... will be able to take advantage of a 33.50% discount price of $399 per year. Analyst’s Disclosure: I/we have ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on prescription drug imports.

Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard ...